Polyrizon Ltd. Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting

Reuters
2025/05/24
<a href="https://laohu8.com/S/PLRZ">Polyrizon Ltd.</a> Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting

Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, has announced that it received a delisting notice from Nasdaq. The delisting is due to concerns over substantial shareholder dilution following the issuance of securities related to a purchase agreement dated March 31, 2025. Although the company's shares are not immediately affected, Polyrizon plans to request a hearing before a Nasdaq Hearings Panel to address the issue. This request will temporarily halt any suspension or delisting actions until the hearing and a subsequent decision by the Panel.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9457098-en) on May 23, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10